← Back to Search

Mobile MCG Device for Acute Coronary Syndrome

N/A

Recruiting

Research Sponsored by SB Technology, Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Presents to ED with symptoms of Acute Coronary Syndrome (ACS)

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up during the procedure (mcg scan)

Awards & highlights

Study Summary

This trial will study if a mobile MCG device can give reliable data in an emergency room setting.

Who is the study for?

This trial is for individuals who arrive at the emergency department with symptoms of Acute Coronary Syndrome (ACS) and can give written consent. It's not for those with ST-Elevation Myocardial Infarction, Atrial Fibrillation, non-ischemic causes like trauma, or active thoracic metal implants.Check my eligibility

What is being tested?

The study is testing the use of a new mobile MCG (magnetocardiography) device in an emergency setting to see if it can collect good data without interfering with normal ED operations.See study design

What are the potential side effects?

Since this trial involves data collection using a non-invasive device rather than medication or invasive procedures, there are no expected side effects from participating.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I went to the emergency room because I might be having a heart attack.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ during the procedure (mcg scan)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~during the procedure (mcg scan)

This trial's timeline: 3 weeks for screening, Varies for treatment, and during the procedure (mcg scan) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

% analyzable Sandbox MCG data

Secondary outcome measures

Characterization of scan results that may differentiate between high risk and low risk ACS patients

Sandbox MCG safety

Trial Design

1Treatment groups

Experimental Treatment

Group I: Sponsor MCG deviceExperimental Treatment1 Intervention

All participants will receive a scan from the Sponsor MCG device

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

SB Technology, Inc.Lead Sponsor

Kit Yee Au-Yeung, PhDStudy DirectorSB Technology, Inc.

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there still an opportunity for participants to join this research endeavor?

"Clinicialtrials.gov's data confirms that this trial is no longer recruiting participants, after first being posted on October 1st 2023 and last edited 18 days later. Despite this particular study having concluded its recruitment process, 343 other medical studies are presently seeking patients to enrol in their trials."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

MCG Discovery Study in Emergency Departments

2023. "MCG Discovery Study in Emergency Departments". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06095557.